lamivudine has been researched along with Disease Models, Animal in 35 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (14.29) | 18.2507 |
2000's | 19 (54.29) | 29.6817 |
2010's | 6 (17.14) | 24.3611 |
2020's | 5 (14.29) | 2.80 |
Authors | Studies |
---|---|
Butler, SD; Cote, PJ; George, AL; Gerin, JL; Menne, S; Tennant, BC; Tochkov, IA; Xiong, S; Zhu, Y | 1 |
Chang, J; Liu, B; Liu, Y; Lu, J; Ma, H; Peng, Y; Qiao, Y; Song, C; Wang, J; Wu, J; Yu, W | 1 |
Clotet, B; Dierssen, M; Elizalde-Torrent, A; Martinez de Lagran, M; Paredes, R | 1 |
Ávila, J; Hernández, F; Vallés-Saiz, L | 1 |
Davis, CC; Hassounah, S; Heredia, A; Kashanchi, F; Le, NM; Medina-Moreno, S; Mesplede, T; Oliveira, M; Zapata, JC | 1 |
Afolayan, S; Agumah, R; Akang, E; Akanmu, AS; Dosumu, O | 1 |
Chayama, K; Chung, TL; Dahari, H; Durso-Cain, K; Ishida, Y; Perelson, AS; Reinharz, V; Tateno, C; Tsuge, M; Uprichard, SL | 1 |
Allweiss, L; Beninati, C; Dandri, M; Giersch, K; Kah, J; Lohse, AW; Lütgehetmann, M; Petersen, J; Pollicino, T; Raffa, G; Urban, S; Volz, T | 1 |
Dong, X; Meng, H; Tian, W; Wang, G; Wei, G; Wu, X; Yuchi, J | 1 |
Chen, M; Girgis, S; Graham, D; Mason, AL; McDougall, C; Montano-Loza, A; Sharon, D; Sis, B; Wasilenko, ST; Zhang, G | 1 |
Akkina, R; Akkina, SR; Habu, Y; Hu, S; Kumar, DM; Neff, CP; Seki, T | 1 |
Fang, Y; Hu, Q; Yang, DL; Zhang, XY; Zhang, ZH; Zhang, ZM | 1 |
Benech, H; Bourry, O; Brochard, P; Calvo, J; Dereudre-Bosquet, N; Kazanji, M; Le Grand, R; Makuwa, M; Martinon, F; Souquiere, S | 1 |
Cook, A; Divi, RL; Einem, TL; Fletcher, SL; Harbaugh, JW; Harbaugh, SW; Kuo, MM; Nagashima, K; Poirier, MC; Shockley, ME; St Claire, MC | 1 |
Bock, CT; Dienes, HP; Klein, C; Kubicka, S; Locarnini, S; Manns, MP; Trautwein, C; Wedemeyer, H; Wüstefeld, T | 1 |
Cote, PJ; Delaney, WE; Gerin, JL; Jacob, JR; Korba, BE; Tennant, BC; Toshkov, I | 1 |
Choi, BC; Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX | 1 |
Cook, JE; Dasgupta, S; Gorry, PR; Middaugh, LD; Terry, EC; Tyor, WR; Wesselingh, SL | 1 |
Han, SH | 1 |
Lei, XY; Li, D; Men, K; Xu, DZ; Yan, YP; Zhang, JX | 1 |
Chen, HS; Feng, LL; Guo, XB; He, JY; Yang, RY; Zhang, FX; Zhu, YT | 1 |
Clayton, MM; Feitelson, MA; Schinazi, RF; Sun, B | 1 |
Chi, H; Dahmen, U; Dirsch, O; Gerlich, WH; Glebe, D; He, L; Kemper, T; Lorenz, H; Lu, M; Roggendorf, M; Wen, Y; Xu, Y; Yao, X | 1 |
Main, J; McCarron, B; Thomas, HC | 1 |
Arazi, J; Ben-Moshe, O; Berr, S; Burakova, T; Dagan, S; Eid, A; Eren, R; Galun, E; Gillard, J; Ilan, E; Jurim, O; Lubin, I; Mansour, TS; Neville, L; Nussbaum, O; Reisner, Y; Shouval, D; Yuen, L | 1 |
Bailey, KW; Korba, BE; Morrey, JD; Sidwell, RW | 1 |
Gendelman, HE; Lanier, ER; Limoges, J; McClernon, DR; Persidsky, Y; Poluektova, L; Rasmussen, J; Ratanasuwan, W; Zelivyanskaya, M | 1 |
Bare, C; Bedard, J; Bogan, MR; Buckheit, RW; Gobbi, A; Linquist-Stepps, VD; McCune, JM; Moreno, ME; Rando, RF; Stoddart, CA | 1 |
Korba, BE; Morrey, JD; Sidwell, RW | 1 |
Cote, P; Gerin, JL; Hornbuckle, W; Korba, BE; Schinazi, R; Tennant, BC | 1 |
Jia, Y; Liu, G; Ren, H; Wang, H; Xiong, Y; Zhang, D; Zhuo, Z | 1 |
Heathcote, EJ; Hoofnagle, JH; Lok, AS | 1 |
Chen, Y; Guo, S; Huang, A; Qi, Z | 1 |
Julander, JG; Morrey, JD; Sidwell, RW | 1 |
4 review(s) available for lamivudine and Disease Models, Animal
Article | Year |
---|---|
Telbivudine: a new nucleoside analogue for the treatment of chronic hepatitis B.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Hepatitis B, Chronic; Humans; Lamivudine; Nucleosides; Pyrimidinones; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Telbivudine; Thymidine | 2005 |
Treatment of chronic viral hepatitis.
Topics: 2-Aminopurine; Animals; Antimetabolites; Antiviral Agents; Carcinoma, Hepatocellular; Disease Models, Animal; Drug Therapy, Combination; Ducks; Famciclovir; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Hepatitis, Animal; Humans; Immunologic Factors; Interferon-alpha; Lamivudine; Liver Cirrhosis; Liver Neoplasms; Male; Marmota; Poultry Diseases; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Tumor Cells, Cultured | 1998 |
Transgenic mice as a chemotherapeutic model for hepatitis B virus infection.
Topics: Administration, Oral; Animals; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Genome, Viral; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B Virus, Woodchuck; Humans; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Polymerase Chain Reaction; Sex Factors; Time Factors; Viral Load; Virus Replication; Zidovudine | 1998 |
Management of hepatitis B: 2000--summary of a workshop.
Topics: Animals; Disease Models, Animal; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; Hepatitis B; Hepatitis B Vaccines; Humans; Interferon-alpha; Lamivudine; Liver Transplantation; Recurrence | 2001 |
31 other study(ies) available for lamivudine and Disease Models, Animal
Article | Year |
---|---|
Antiviral effects of lamivudine, emtricitabine, adefovir dipivoxil, and tenofovir disoproxil fumarate administered orally alone and in combination to woodchucks with chronic woodchuck hepatitis virus infection.
Topics: Adenine; Animals; Antigens, Viral; Antiviral Agents; Deoxycytidine; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Emtricitabine; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Humans; Lamivudine; Liver; Marmota; Organophosphonates; RNA, Viral; Rodent Diseases; Tenofovir; Virus Replication | 2008 |
Design, synthesis, and biological evaluation of new 1,2,3-triazolo-2'-deoxy-2'-fluoro- 4'-azido nucleoside derivatives as potent anti-HBV agents.
Topics: Animals; Antiviral Agents; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Ducks; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatitis B Virus, Duck; Humans; Models, Molecular; Molecular Structure; Monosaccharides; Nucleosides; Structure-Activity Relationship; Triazoles; Virus Replication | 2018 |
Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
Topics: Animals; Cognition; Disease Models, Animal; Down Syndrome; Lamivudine; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors | 2022 |
Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.
Topics: Animals; Disease Models, Animal; HeLa Cells; Humans; Lamivudine; Mice; Mice, Transgenic; Reverse Transcriptase Inhibitors; tau Proteins; Tauopathies | 2023 |
Lamivudine-resistant HIV
Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Combinations; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; Humans; Lamivudine; Mice; Mutation; Oxazines; Piperazines; Pyridones; Treatment Outcome | 2020 |
Modeling cerebellar limb dysmetria and impaired spatial memory in rats using lamivudine: A preliminary study.
Topics: Alkynes; Animals; Benzoxazines; Cerebellar Ataxia; Cyclopropanes; Disease Models, Animal; Lamivudine; Male; Maze Learning; Rats; Rats, Wistar; Spatial Memory; Tenofovir | 2020 |
Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
Topics: Animals; Antiviral Agents; Child, Preschool; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Infant; Interferon-alpha; Kinetics; Lamivudine; Liver Transplantation; Male; Mice, SCID; Models, Theoretical; Polyethylene Glycols; Recombinant Proteins; Serum Albumin; Transplantation Chimera | 2021 |
Proliferation of primary human hepatocytes and prevention of hepatitis B virus reinfection efficiently deplete nuclear cccDNA in vivo.
Topics: Animals; Cell Division; Cell Proliferation; Chimera; Disease Models, Animal; DNA, Circular; DNA, Viral; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatocytes; Humans; Keratin-18; Lamivudine; Lipopeptides; Mice; Primary Cell Culture; Recurrence; Reverse Transcriptase Inhibitors; Viral Load; Virus Integration; Virus Replication | 2018 |
[Anti-HBV effect of nucleotide analogues on mouse model of chronic HBV infection mediated by recombinant adeno-associated virus 8].
Topics: Animals; Antiviral Agents; Dependovirus; Disease Models, Animal; Genetic Vectors; Genome, Viral; Guanine; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis B, Chronic; Lamivudine; Mice; Mice, Inbred C57BL; Nucleotides; Transduction, Genetic; Virus Replication | 2013 |
Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease.
Topics: Amino Acid Sequence; Animals; Anti-Retroviral Agents; Biomarkers; Cholangitis; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; Lamivudine; Liver Cirrhosis, Biliary; Lopinavir; Mammary Tumor Virus, Mouse; Mice, Inbred NOD; Molecular Sequence Data; Protease Inhibitors; Retroviridae Infections; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; Time Factors; Tumor Virus Infections; Viral Load; Zidovudine | 2015 |
A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
Topics: Animals; Anti-HIV Agents; CD4-Positive T-Lymphocytes; Dideoxynucleosides; Disease Models, Animal; Drug Therapy, Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-2; Humans; Lamivudine; Mice; Mice, Inbred BALB C; Oxazines; Piperazines; Pyridones | 2017 |
[Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Topics: Animals; Animals, Newborn; Disease Models, Animal; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Liver; Reverse Transcriptase Inhibitors; Viremia | 2008 |
Prevention of vaginal simian immunodeficiency virus transmission in macaques by postexposure prophylaxis with zidovudine, lamivudine and indinavir.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Indinavir; Injections, Subcutaneous; Lamivudine; Macaca fascicularis; Sexually Transmitted Diseases, Viral; Simian Acquired Immunodeficiency Syndrome; Vagina; Viral Load; Viremia; Zidovudine | 2009 |
Progressive mitochondrial compromise in brains and livers of primates exposed in utero to nucleoside reverse transcriptase inhibitors (NRTIs).
Topics: Animals; Animals, Newborn; Cerebral Cortex; Didanosine; Disease Models, Animal; DNA, Mitochondrial; Drug Therapy, Combination; Erythrocebus patas; Female; Lamivudine; Maternal Exposure; Mitochondria, Liver; Oxidative Phosphorylation; Pregnancy; Reverse Transcriptase Inhibitors; Stavudine; Zidovudine | 2010 |
Inhibition of hepatitis B virus replication in vivo by nucleoside analogues and siRNA.
Topics: Adenine; Animals; Capsid; Combined Modality Therapy; Disease Models, Animal; Gene Expression Regulation, Viral; Genetic Therapy; Hepatitis B; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Lamivudine; Liver; Male; Mice; Mice, Inbred Strains; Organophosphonates; Reverse Transcriptase Inhibitors; RNA, Small Interfering; Specific Pathogen-Free Organisms; Virus Replication | 2003 |
Suppression of lamivudine-resistant B-domain mutants by adefovir dipivoxil in the woodchuck hepatitis virus model.
Topics: Adenine; Administration, Oral; Amino Acid Motifs; Amino Acid Substitution; Animals; Antiviral Agents; Disease Models, Animal; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Hepatitis B; Hepatitis B Virus, Woodchuck; Lamivudine; Marmota; Mutation, Missense; Organophosphonates; Protein Structure, Tertiary; Viremia; Virus Replication | 2004 |
Preliminary study on the efficacy and safety of lamivudine and interferon alpha therapy in decreasing serum HBV DNA level in HBV positive transgenic mice during pregnancy.
Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Viremia | 2005 |
Highly active antiretroviral therapy and human immunodeficiency virus encephalitis.
Topics: AIDS Dementia Complex; Animals; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Brain; Disease Models, Animal; Drug Therapy, Combination; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mice; Mice, SCID; Monocytes; Viral Load; Zidovudine | 2005 |
[Study on efficacy and safety of lamivudine and interferon-alpha in treatment of hepatitis B virus transgenic mice with pregnancy].
Topics: Animals; Antiviral Agents; Disease Models, Animal; Drug Administration Routes; Female; Hepatitis B; Hepatitis B virus; Interferon-alpha; Lamivudine; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pregnancy; Pregnancy Complications, Infectious; Random Allocation; Viral Load | 2005 |
Mutations outside the YMDD motif in the P protein can also cause DHBV resistant to Lamivudine.
Topics: Amino Acid Sequence; Animals; Chick Embryo; Disease Models, Animal; Drug Resistance, Viral; Ducks; Gene Products, pol; Hepatitis B; Hepatitis B virus; Lamivudine; Molecular Sequence Data; Reverse Transcriptase Inhibitors | 2005 |
Development of a novel mouse model to evaluate drug candidates against hepatitis B virus.
Topics: Adenine; Animals; Antiviral Agents; Cell Line; Disease Models, Animal; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B virus; Lamivudine; Mice; Mice, Nude; Organophosphonates; Reproducibility of Results; Tenofovir | 2007 |
Combination of an antiviral drug and immunomodulation against hepadnaviral infection in the woodchuck model.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Hepadnaviridae Infections; Lamivudine; Marmota; Plasmids; Vaccines, DNA | 2008 |
The hepatitis B virus-trimera mouse: a model for human HBV infection and evaluation of anti-HBV therapeutic agents.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Deoxycytidine; Disease Models, Animal; DNA, Viral; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Kidney; Lamivudine; Liver; Liver Transplantation; Mice; Mice, Inbred NOD; Mice, SCID; Polymerase Chain Reaction; RNA, Messenger; Serum Albumin; Viremia | 1999 |
Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine.
Topics: Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis, Viral, Animal; Humans; Lamivudine; Male; Mice; Mice, Transgenic; Time Factors; Treatment Outcome; Virus Replication; Zidovudine | 1999 |
Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice.
Topics: AIDS Dementia Complex; Animals; Cells, Cultured; Didanosine; Dideoxynucleosides; Disease Models, Animal; HIV-1; Humans; Lamivudine; Male; Mice; Mice, SCID; Monocytes; Reverse Transcriptase Inhibitors; Stavudine; Virus Replication; Zidovudine | 2000 |
Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.
Topics: Animals; Anti-HIV Agents; Deoxycytidine; Disease Models, Animal; Drug Resistance, Microbial; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Lamivudine; Leukocytes, Mononuclear; Mice; Mice, SCID; Reverse Transcriptase Inhibitors; Thionucleosides; Virus Replication | 2000 |
Enhanced antiviral benefit of combination therapy with lamivudine and famciclovir against WHV replication in chronic WHV carrier woodchucks.
Topics: 2-Aminopurine; Animals; Antiviral Agents; Carrier State; Disease Models, Animal; Drug Therapy, Combination; Famciclovir; Hepatitis B Virus, Woodchuck; Hepatitis B, Chronic; Lamivudine; Marmota; Prodrugs; Reverse Transcriptase Inhibitors; Viremia; Virus Replication | 2000 |
HE2000 shows efficacy.
Topics: Animals; Anti-HIV Agents; Disease Models, Animal; Drugs, Investigational; Haplorhini; Lamivudine; Ritonavir; Simian Acquired Immunodeficiency Syndrome; Survival Analysis; Viral Load; Zidovudine | 1999 |
Hepatitis B virus transgenic mice for the model of anti-hepatitis B virus drug study.
Topics: Animals; Antiviral Agents; Disease Models, Animal; Female; Hepatitis B; Hepatitis B virus; Lamivudine; Male; Mice; Mice, Transgenic; Thymosin; Vaccines, DNA | 2001 |
[Experimental study on the effect of combination therapy with lamivudine and famciclovir against duck hepatitis B virus in vivo].
Topics: 2-Aminopurine; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Drug Therapy, Combination; Ducks; Famciclovir; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Lamivudine; Microbial Sensitivity Tests | 2001 |
Characterizing antiviral activity of adefovir dipivoxil in transgenic mice expressing hepatitis B virus.
Topics: Adenine; Administration, Oral; Animals; Antiviral Agents; Disease Models, Animal; DNA, Viral; Dose-Response Relationship, Drug; Hepatitis B; Hepatitis B virus; Lamivudine; Liver; Mice; Mice, Transgenic; Organophosphonates; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Viral Load | 2002 |